Korea Exchange will review whether to delist biotech company SillaJen Inc. due to the indictment of embezzlement and breach of trust charges against its officials.
Company executives were suspected of avoiding massive losses by selling large amounts of stocks ahead of its regulatory filing in August 2019, using inside information that its key product Pexa-Vec failed clinical tests.
Prosecutors also suspect that former Sillajen CEO Moon Eun-sang acquired a stake in the company without any capital by taking over bonds with warrants.
Moon resigned last week as Sillajen CEO after a warrant of arrest was issued against him by the Seoul Southern District Court for using undisclosed information to sell SillaJen stocks and committing other irregularities.
The resignation was also perceived as a means to help SillaJen avoid a delisting.
Top managers’ alleged embezzlement can be a basis for a company to lose eligibility for listing on the stock market.
KOSDAQ has suspended trading of SillaJen stocks since May 4.


Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Zhongji Innolight Raises $6.8 Billion in Hong Kong IPO as AI Demand Fuels Growth
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Qualcomm Stock Falls as Weak Q4 Forecast, Apple Revenue Decline Overshadow AI Data Center Growth
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
X Challenges Australia’s Expanded Social Media Ban Enforcement Powers
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
Standard Chartered Beats Profit Forecasts as First-Half Earnings Rise 9%
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Exosens H1 Profit Beats Forecasts as Defense Demand Drives Growth
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook 



